Thanks Paul. This is VERY interesting. Maybe, with this being presented at the ASH in San Diego this year, it will motivate the US to move forward with our trials in a more aggressive way.
I’m wondering if the big question is how would a three year trial of Ropeg compare with Pegasys? Ropeg apppears better tolerated (now similar to HU albeit only after 3 years) but would Pegasys have comparable haematological/molecular response?
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.